Business Description
Roivant Sciences Ltd
ISIN : BMG762791017
Share Class Description:
ROIV: Ordinary SharesDescription
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.17 | |||||
| Equity-to-Asset | 0.83 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.12 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 10.4 | |||||
| Beneish M-Score | -1.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.24 | |||||
| 9-Day RSI | 57.58 | |||||
| 14-Day RSI | 54.34 | |||||
| 6-1 Month Momentum % | 19.29 | |||||
| 12-1 Month Momentum % | 16.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 27.79 | |||||
| Quick Ratio | 27.77 | |||||
| Cash Ratio | 27.24 | |||||
| Days Inventory | 102.02 | |||||
| Days Sales Outstanding | 111.72 | |||||
| Days Payable | 1025.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -0.71 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.57 | |||||
| Operating Margin % | -850.46 | |||||
| Net Margin % | 3624.14 | |||||
| FCF Margin % | -680.42 | |||||
| ROE % | 221.94 | |||||
| ROA % | 138.64 | |||||
| ROIC % | -155.53 | |||||
| ROC (Joel Greenblatt) % | 5195.09 | |||||
| ROCE % | 144.99 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.12 | |||||
| PS Ratio | 70.81 | |||||
| PB Ratio | 1.46 | |||||
| Price-to-Tangible-Book | 1.49 | |||||
| EV-to-EBIT | 0.61 | |||||
| EV-to-EBITDA | 0.6 | |||||
| EV-to-Revenue | 21.12 | |||||
| EV-to-Forward-Revenue | 11.25 | |||||
| EV-to-FCF | -3.1 | |||||
| Price-to-Net-Current-Asset-Value | 1.59 | |||||
| Price-to-Net-Cash | 1.63 | |||||
| Earnings Yield (Greenblatt) % | 163.93 | |||||
| FCF Yield % | -9.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ROIV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Roivant Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 123.241 | ||
| EPS (TTM) ($) | 5.2 | ||
| Beta | 0 | ||
| Volatility % | 47.61 | ||
| 14-Day RSI | 54.34 | ||
| 14-Day ATR ($) | 0.364306 | ||
| 20-Day SMA ($) | 10.981 | ||
| 12-1 Month Momentum % | 16.67 | ||
| 52-Week Range ($) | 8.06 - 13.24 | ||
| Shares Outstanding (Mil) | 805.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Roivant Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Roivant Sciences Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Roivant Sciences Ltd Frequently Asked Questions
What is Roivant Sciences Ltd(ROIV)'s stock price today?
The current price of ROIV is $11.03. The 52 week high of ROIV is $13.24 and 52 week low is $8.06.
When is next earnings date of Roivant Sciences Ltd(ROIV)?
The next earnings date of Roivant Sciences Ltd(ROIV) is 2024-06-28 Est..
Does Roivant Sciences Ltd(ROIV) pay dividends? If so, how much?
Roivant Sciences Ltd(ROIV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers